Literature DB >> 16054271

Aluminium phosphate potentiates the efficacy of DNA vaccines against Leishmania mexicana.

Miguel Rosado-Vallado1, Mirza Mut-Martin, Maria del Rosario García-Miss, Eric Dumonteil.   

Abstract

DNA vaccines have been able to induce partial protection against infection with Leishmania in mice, but it is still necessary to increase their efficacy. In the present study we evaluated aluminium phosphate as an adjuvant of different formulations and doses of DNA vaccines against L. mexicana in BALB/c mice. Aluminium phosphate had no effect on the humoral response induced by a high dose (100 microg) DNA vaccine, but slightly increased the cellular response and the protection against infection. It also allowed a non-immunoprotective low dose (20 microg) DNA vaccine encoding L. mexicana GP63 and Leishmania donovani NH36 to become protective. Aluminium phosphate may thus be an effective, low cost and safe adjuvant for DNA vaccines, and the vaccine formulation described here may be an excellent candidate for further vaccine development against Leishmania.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054271     DOI: 10.1016/j.vaccine.2005.05.037

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

2.  The role of Montanide ISA 70 as an adjuvant in immune responses against Leishmania major induced by thiol-specific antioxidant-based protein vaccine.

Authors:  Narges Khabazzadeh Tehrani; Mehdi Mahdavi; Fatemeh Maleki; Somayeh Zarrati; Fatemeh Tabatabaie
Journal:  J Parasit Dis       Date:  2014-09-20

3.  Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii.

Authors:  Kamy Hosseinian Khosroshahi; Fatemeh Ghaffarifar; Zohre Sharifi; Sushila D'Souza; Abdolhosein Dalimi; Zuhair M Hassan; Fariba Khoshzaban
Journal:  Parasitol Res       Date:  2012-02-21       Impact factor: 2.289

4.  Th1 Platform Immune Responses Against Leishmania major Induced by Thiol-Specific Antioxidant-Based DNA Vaccines.

Authors:  Fatemeh Tabatabaie; Mehdi Mahdavi; Sobhan Faezi; Abdolhossein Dalimi; Zohreh Sharifi; Lame Akhlaghi; Fatemeh Ghaffarifar
Journal:  Jundishapur J Microbiol       Date:  2014-02-01       Impact factor: 0.747

5.  Assessment of DNA vaccine encoding Toxoplasma gondii microneme complete gene and IL-12 as adjuvant in BALB/c mice.

Authors:  Fatemeh Ghaffarifar; Mohammad Jafarimodrek; Hossein Vazini; Zohreh Sharifi; Abdolhossein Dalimi; Mohammad Saaid Dayer
Journal:  Iran J Basic Med Sci       Date:  2019-08       Impact factor: 2.699

6.  DNA Vaccines against Protozoan Parasites: Advances and Challenges.

Authors:  Eric Dumonteil
Journal:  J Biomed Biotechnol       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.